Showing results (241-250 of 346) with videos related to

Sort By:
Pageof 35
Cancer Treatment Reports|April 1, 1985
Activity of JM9 in advanced ovarian cancer: a phase I-II trialV H Bramwell, D Crowther, S O'Malley, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1985
A prospective study of the treatment of high-grade histology non-Hodgkin's lymphoma involving the gastrointestinal tractW P Steward, M Harris, J Wagstaff, et al.
British Journal of Cancer|May 1, 1990
Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancerW P Steward, J H Scarffe, L Y Dirix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaC Straka, R Pettengell, A Pielmeier, et al.
British Journal of Cancer|March 1, 1994
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical featuresJ Renninson, B W Baker, A T McGown, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction techniqueP Khan, A T McGown, M J Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Ciba Foundation Symposium|January 1, 1990
Growth factor-assisted chemotherapy--the Manchester experienceD Crowther, J H Scarffe, A Howell, et al.
Lancet (London, England)|May 8, 1982
11-week course of sequential methotrexate, thoracic irradiation, and moderate-dose cyclophosphamide for "limited"-stage small-cell bronchogenic carcinoma. A study from the Manchester Lung Tumour GroupN Thatcher, P V Barber, R D Hunter, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseaseN Thatcher, H Sharma, R Harrison, et al.
Pageof 35